nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—exocrine gland—cervical cancer	0.0438	0.121	CbGeAlD
Ingenol Mebutate—PRKCD—decidua—cervical cancer	0.0326	0.0901	CbGeAlD
Ingenol Mebutate—PRKCD—renal system—cervical cancer	0.032	0.0884	CbGeAlD
Ingenol Mebutate—PRKCD—endometrium—cervical cancer	0.031	0.0855	CbGeAlD
Ingenol Mebutate—PRKCD—mammalian vulva—cervical cancer	0.03	0.0827	CbGeAlD
Ingenol Mebutate—PRKCD—female reproductive system—cervical cancer	0.0257	0.0708	CbGeAlD
Ingenol Mebutate—PRKCD—female gonad—cervical cancer	0.0233	0.0644	CbGeAlD
Ingenol Mebutate—PRKCD—vagina—cervical cancer	0.0232	0.064	CbGeAlD
Ingenol Mebutate—PRKCA—epithelium—cervical cancer	0.019	0.0526	CbGeAlD
Ingenol Mebutate—PRKCA—decidua—cervical cancer	0.018	0.0496	CbGeAlD
Ingenol Mebutate—PRKCA—renal system—cervical cancer	0.0177	0.0487	CbGeAlD
Ingenol Mebutate—PRKCA—uterus—cervical cancer	0.0157	0.0434	CbGeAlD
Ingenol Mebutate—PRKCD—lymph node—cervical cancer	0.015	0.0414	CbGeAlD
Ingenol Mebutate—PRKCA—female reproductive system—cervical cancer	0.0141	0.039	CbGeAlD
Ingenol Mebutate—PRKCA—female gonad—cervical cancer	0.0129	0.0355	CbGeAlD
Ingenol Mebutate—PRKCA—lymph node—cervical cancer	0.00827	0.0228	CbGeAlD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—MTOR—cervical cancer	0.00138	0.00216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway—CTNNB1—cervical cancer	0.00133	0.00208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—WNT5A—cervical cancer	0.00133	0.00208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—cervical cancer	0.00131	0.00206	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—TP53—cervical cancer	0.00131	0.00205	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—CASP3—cervical cancer	0.0013	0.00204	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Insulin Signaling—MTOR—cervical cancer	0.0013	0.00204	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—MTOR—cervical cancer	0.00129	0.00203	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—MTOR—cervical cancer	0.00129	0.00202	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	0.00129	0.00202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Kit receptor signaling pathway—STAT3—cervical cancer	0.00128	0.00201	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—MTOR—cervical cancer	0.00128	0.00201	CbGpPWpGaD
Ingenol Mebutate—PRKCD—ErbB1 downstream signaling—EGFR—cervical cancer	0.00128	0.002	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—MTOR—cervical cancer	0.00127	0.002	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—CTNNB1—cervical cancer	0.00125	0.00196	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—EGFR—cervical cancer	0.00125	0.00196	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—CASP3—cervical cancer	0.00123	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCD—PDGFR-beta signaling pathway—STAT3—cervical cancer	0.00122	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Thromboxane A2 receptor signaling—EGFR—cervical cancer	0.00121	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—WNT2—cervical cancer	0.0012	0.00189	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—MTOR—cervical cancer	0.0012	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—MTOR—cervical cancer	0.0012	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—MTOR—cervical cancer	0.00119	0.00186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—STAT3—cervical cancer	0.00119	0.00186	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—CTNNB1—cervical cancer	0.00118	0.00185	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—MTOR—cervical cancer	0.00118	0.00185	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—FGFR3—cervical cancer	0.00117	0.00184	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—MTOR—cervical cancer	0.00117	0.00184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—STAT3—cervical cancer	0.00117	0.00184	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKAP13—cervical cancer	0.00116	0.00182	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—FGFR3—cervical cancer	0.00116	0.00182	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—CASP3—cervical cancer	0.00115	0.0018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—FGFR3—cervical cancer	0.00112	0.00176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—TP53—cervical cancer	0.0011	0.00172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—STAT3—cervical cancer	0.00109	0.00171	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—UBE3A—cervical cancer	0.00108	0.0017	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—CASP3—cervical cancer	0.00107	0.00168	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—EGFR—cervical cancer	0.00106	0.00167	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.00106	0.00166	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKAP13—cervical cancer	0.00106	0.00166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—FGFR3—cervical cancer	0.00106	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—FGFR3—cervical cancer	0.00105	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—TP53—cervical cancer	0.00105	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—MTOR—cervical cancer	0.00105	0.00164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—FGFR3—cervical cancer	0.00105	0.00164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—FGFR3—cervical cancer	0.00104	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—CTNNB1—cervical cancer	0.00103	0.00161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—MTOR—cervical cancer	0.00103	0.00161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—WNT2—cervical cancer	0.00101	0.00159	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—STAT3—cervical cancer	0.000999	0.00157	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	0.000994	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—FGFR3—cervical cancer	0.000978	0.00153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—FGFR3—cervical cancer	0.000978	0.00153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—TAAR6—cervical cancer	0.000975	0.00153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—MTOR—cervical cancer	0.000972	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—FGFR3—cervical cancer	0.00097	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—EGFR—cervical cancer	0.000966	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—FGFR3—cervical cancer	0.000961	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—FGFR3—cervical cancer	0.000957	0.0015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—CTNNB1—cervical cancer	0.000948	0.00149	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—STAT3—cervical cancer	0.000926	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—CTNNB1—cervical cancer	0.000913	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—WNT5A—cervical cancer	0.000912	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TAAR6—cervical cancer	0.00091	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—EGFR—cervical cancer	0.000908	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—STAT3—cervical cancer	0.000906	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TP53—cervical cancer	0.000905	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—EGFR—cervical cancer	0.000904	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	0.000904	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—EGFR—cervical cancer	0.000899	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—EGFR—cervical cancer	0.000895	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—EGFR—cervical cancer	0.000895	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TAAR6—cervical cancer	0.000885	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—RARB—cervical cancer	0.000878	0.00138	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—EGFR—cervical cancer	0.000878	0.00138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—CASP3—cervical cancer	0.000876	0.00137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	0.000867	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—CTNNB1—cervical cancer	0.000862	0.00135	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—EGFR—cervical cancer	0.000842	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—EGFR—cervical cancer	0.000842	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—EGFR—cervical cancer	0.000834	0.00131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000827	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—MTOR—cervical cancer	0.000826	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—EGFR—cervical cancer	0.000823	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.00082	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—MTOR—cervical cancer	0.000816	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—STAT3—cervical cancer	0.000808	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—MTOR—cervical cancer	0.00079	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000787	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TP53—cervical cancer	0.000786	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—WNT5A—cervical cancer	0.000769	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—cervical cancer	0.000751	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—CASP3—cervical cancer	0.000751	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—MTOR—cervical cancer	0.000746	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000746	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—MTOR—cervical cancer	0.000742	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—MTOR—cervical cancer	0.000739	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	0.000739	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—cervical cancer	0.000737	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—MTOR—cervical cancer	0.000735	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—EGFR—cervical cancer	0.000734	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—MTOR—cervical cancer	0.000732	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—beta-catenin independent WNT signaling—CTNNB1—cervical cancer	0.000724	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00072	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—WNT2—cervical cancer	0.000711	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—STAT3—cervical cancer	0.000703	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—WNT2—cervical cancer	0.000691	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—MTOR—cervical cancer	0.000688	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—MTOR—cervical cancer	0.000688	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—MTOR—cervical cancer	0.000682	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—MTOR—cervical cancer	0.000676	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—MTOR—cervical cancer	0.000673	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—TERT—cervical cancer	0.000669	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—EGFR—cervical cancer	0.000669	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKAP13—cervical cancer	0.000668	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGFR3—cervical cancer	0.000666	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGFR3—cervical cancer	0.000662	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HLA-DPB1—cervical cancer	0.000647	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.000642	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—STAT3—cervical cancer	0.000638	0.001	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—STAT3—cervical cancer	0.000631	0.000989	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—cervical cancer	0.000631	0.000989	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKAP13—cervical cancer	0.000624	0.000978	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—UBE3A—cervical cancer	0.000622	0.000975	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.00061	0.000956	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKAP13—cervical cancer	0.000607	0.000951	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000596	0.000934	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—WNT2—cervical cancer	0.000583	0.000914	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—NOTCH2—cervical cancer	0.000581	0.000912	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—EGFR—cervical cancer	0.00058	0.000909	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000574	0.0009	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—STAT3—cervical cancer	0.000574	0.0009	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—EGFR—cervical cancer	0.000573	0.000899	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	0.000571	0.000895	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CASP8—cervical cancer	0.000566	0.000887	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—cervical cancer	0.000561	0.00088	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—EGFR—cervical cancer	0.000555	0.00087	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—WNT5A—cervical cancer	0.000539	0.000845	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—STAT3—cervical cancer	0.000532	0.000834	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—WNT5A—cervical cancer	0.000524	0.000821	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TAAR6—cervical cancer	0.000523	0.00082	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—EGFR—cervical cancer	0.000522	0.000818	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—STAT3—cervical cancer	0.00052	0.000816	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—EGFR—cervical cancer	0.000519	0.000814	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	0.000519	0.000814	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—EGFR—cervical cancer	0.000516	0.00081	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—EGFR—cervical cancer	0.000514	0.000806	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HLA-DQB1—cervical cancer	0.000505	0.000791	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—RARB—cervical cancer	0.000504	0.00079	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—EGFR—cervical cancer	0.000483	0.000758	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—EGFR—cervical cancer	0.000483	0.000758	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—EGFR—cervical cancer	0.000479	0.000751	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000475	0.000745	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—EGFR—cervical cancer	0.000473	0.000741	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD8A—cervical cancer	0.000471	0.000739	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.000471	0.000739	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—MTOR—cervical cancer	0.000469	0.000735	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—MTOR—cervical cancer	0.000466	0.00073	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CD4—cervical cancer	0.000465	0.000729	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CA9—cervical cancer	0.000461	0.000723	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—CASP3—cervical cancer	0.00046	0.000721	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000455	0.000713	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HES1—cervical cancer	0.000443	0.000694	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—WNT5A—cervical cancer	0.000442	0.000693	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TERT—cervical cancer	0.000434	0.000681	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CASP3—cervical cancer	0.000431	0.000676	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000428	0.000671	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000414	0.000649	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CTNNB1—cervical cancer	0.000413	0.000647	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—WNT2—cervical cancer	0.000408	0.00064	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MTHFR—cervical cancer	0.000389	0.00061	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TERT—cervical cancer	0.000388	0.000608	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGFR3—cervical cancer	0.000385	0.000604	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—CTNNB1—cervical cancer	0.000383	0.0006	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000382	0.000599	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGFR3—cervical cancer	0.00038	0.000596	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOTCH2—cervical cancer	0.000378	0.000593	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-DPB1—cervical cancer	0.000371	0.000582	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—STAT3—cervical cancer	0.000362	0.000568	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—NOTCH1—cervical cancer	0.00036	0.000564	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKAP13—cervical cancer	0.000358	0.000562	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGFR3—cervical cancer	0.000356	0.000558	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOTCH1—cervical cancer	0.000334	0.000524	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NOTCH2—cervical cancer	0.000334	0.000524	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CASP8—cervical cancer	0.00033	0.000517	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—cervical cancer	0.000329	0.000516	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—cervical cancer	0.000327	0.000513	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CASP8—cervical cancer	0.000325	0.00051	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HES1—cervical cancer	0.00031	0.000486	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—WNT5A—cervical cancer	0.000309	0.000485	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—cervical cancer	0.000305	0.000478	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HLA-DQB1—cervical cancer	0.00029	0.000455	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TERT—cervical cancer	0.000272	0.000426	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MTOR—cervical cancer	0.000271	0.000425	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD8A—cervical cancer	0.000271	0.000424	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD4—cervical cancer	0.000271	0.000424	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MTOR—cervical cancer	0.000267	0.000419	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CD4—cervical cancer	0.000267	0.000419	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HES1—cervical cancer	0.000254	0.000399	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MTOR—cervical cancer	0.00025	0.000393	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CD4—cervical cancer	0.00025	0.000392	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGFR3—cervical cancer	0.000249	0.000391	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTNNB1—cervical cancer	0.00024	0.000377	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTNNB1—cervical cancer	0.000237	0.000372	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOTCH1—cervical cancer	0.000234	0.000367	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTHFR—cervical cancer	0.000223	0.00035	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TERT—cervical cancer	0.000223	0.000349	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CTNNB1—cervical cancer	0.000222	0.000348	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGFR3—cervical cancer	0.000221	0.000347	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH2—cervical cancer	0.000217	0.00034	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—STAT3—cervical cancer	0.00021	0.000329	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—cervical cancer	0.000208	0.000327	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NOTCH1—cervical cancer	0.000207	0.000324	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGFR3—cervical cancer	0.000204	0.000321	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—STAT3—cervical cancer	0.000194	0.000303	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOTCH1—cervical cancer	0.000192	0.000301	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—cervical cancer	0.00019	0.000299	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CASP8—cervical cancer	0.000189	0.000297	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—cervical cancer	0.000188	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MTHFR—cervical cancer	0.000187	0.000293	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HES1—cervical cancer	0.000178	0.000279	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—cervical cancer	0.000176	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MTOR—cervical cancer	0.000175	0.000275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—cervical cancer	0.000175	0.000275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—cervical cancer	0.000165	0.000259	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CASP3—cervical cancer	0.000161	0.000253	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TERT—cervical cancer	0.000156	0.000245	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MTOR—cervical cancer	0.000156	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD4—cervical cancer	0.000155	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CTNNB1—cervical cancer	0.000155	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTOR—cervical cancer	0.000144	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CD4—cervical cancer	0.000144	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGFR3—cervical cancer	0.000143	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTNNB1—cervical cancer	0.000138	0.000217	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—STAT3—cervical cancer	0.000136	0.000212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH1—cervical cancer	0.000134	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CTNNB1—cervical cancer	0.000127	0.0002	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—cervical cancer	0.000123	0.000193	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—STAT3—cervical cancer	0.00012	0.000189	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—cervical cancer	0.00012	0.000188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—STAT3—cervical cancer	0.000111	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—cervical cancer	0.000109	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—cervical cancer	0.000103	0.000162	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—cervical cancer	0.000101	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MTOR—cervical cancer	0.000101	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CASP3—cervical cancer	9.26e-05	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CTNNB1—cervical cancer	8.93e-05	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STAT3—cervical cancer	7.78e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—cervical cancer	7.07e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—cervical cancer	5.94e-05	9.31e-05	CbGpPWpGaD
